In 2023, Eli Lilly synthesized injectable retatrutide, the first triple-action agonist targeting GLP-1, GIP, and glucagon receptors, which is currently undergoing Phase 3 clinical trials
This medication works by mimicking a naturally occurring hormone called glucagon-like-peptide-1 (GLP-1), which helps regulate appetite and blood sugar levels
Bibliography Stephens FB, Constantin-Teodosiu D, Greenhaff PL (2007)
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) on a monthly commitment plan
After you eat, go for a 10 to 15-minute stroll, and see if it helps you feel better
Semaglutide comes both as an injection and a tablet